A subscription to JoVE is required to view this content. Sign in or start your free trial.
This study presents a protocol for establishing a highly reproducible animal model of hemorrhagic transformation (HT) using middle cerebral artery occlusion/reperfusion (MCAO/R) in C57BL/6 mice with acute hyperglycemia.
Hemorrhagic transformation (HT) is a serious complication that can occur as a result of thrombolytic therapy following ischemic stroke (IS), and it poses significant limitations on the clinical application of recombinant tissue plasminogen activator (rt-PA). Unfortunately, there are currently no effective interventions available for HT in clinical practice. Therefore, there is an urgent need for stable and reliable experimental animal models to elucidate the pathogenesis of HT and develop effective intervention strategies. This study presented a protocol for establishing a mouse model of HT induced by acute hyperglycemia combined with transient focal ischemia (tMCAO). Male C57BL/6J mice were injected with 30% glucose to induce hyperglycemia and then subjected to 60 min of tMCAO with reperfusion. The infarct volume, integrity of the blood-brain barrier (BBB), and degree of intracranial hemorrhage were assessed at 24 h after MCAO. The results showed that glucose injection led to transient hyperglycemia (14.3-20.3 mmol/L), which significantly increased both the infarct volume and the incidence of HT. Hematoxylin-eosin (H&E) staining indicated significant hemorrhagic lesions within the infarction zone in hyperglycemic mice. Additionally, hyperglycemic mice exhibited aggravated BBB disruption, as shown by more severe leakage of Evans blue (EB) and FITC-Dextran. In conclusion, acute hyperglycemia reliably and consistently resulted in macroscopic HT in a mouse model of tMCAO. This reproducible model offers a valuable tool for investigating the pathological mechanisms of HT and developing corresponding therapeutic interventions.
Cerebral infarction is the primary cause of disability and the second leading cause of death in adults worldwide1. The acute phase plays a crucial role in the progression of cerebral infarction, serving as a pivotal time point for disease treatment. Early and timely restoration of blood flow in the penumbra area is essential to prevent further brain cell death, with thrombolysis and interventional therapy representing the mainstays for acute cerebral infarction (ACI) treatment. However, hemorrhagic transformation (HT) poses a significant complication following thrombolysis and interventional therapy, occurring in 15%-30% of patients with ischem....
The experimental protocol was approved by the Institutional Animal Care and Use Committee of Jianghan University (JHDXLL2024-080) and conducted in accordance with the Experimental Animal Ethical Guidelines issued by the Center for Disease Control of China. Adult male C57BL/6J mice weighing 21-26 g were used in this study. The details of the reagents and equipment used are listed in the Table of Materials.
1. Animal grouping and acute hyperglycemia inducing
<.......The experimental procedure of this study is illustrated in Figure 1. Briefly, the mice underwent thread occlusion-induced MCAO for 60 min, followed by reperfusion. Glucose (30% in normal saline, 7.2 mL/kg body weight) was intraperitoneally administered 15 min before MCAO. Blood glucose levels were measured at baseline (before glucose injection), immediately after MCAO, and at the time of reperfusion. After 24 h of reperfusion, the mice were euthanized, and brain tissues were.......
The current protocol is designed to create a reliable animal model of hemorrhagic transformation following ischemic stroke, which can replicate the harmful effects of vessel revascularization under hyperglycemic conditions. Among the various risk factors for ischemic stroke, the blood glucose level within 24 h after the onset of stroke is positively correlated with the exacerbation of cerebral injury and increased mortality3,18. Numerous clinical investigations h.......
Figure 1 was created with BioRender software (https://www.biorender.com/). This study was supported by grants from the guiding project of the Natural Science Foundation of Hubei Province (No. 2022CFC057).
....Name | Company | Catalog Number | Comments |
2,3,5-Triphenyltetrazolium Chloride (TTC) | Sigma-Aldrich | 108380 | The dye for TTC staining |
24-well culture plate | Corning Incorporated | CLS3527 | The vessel for TTC staining |
30% glucose injection | Kelun Pharmaceutical | H42021188 | Acute hyperglycemia induction |
4% paraformaldehyde | Wuhan Servicebio Technology Co., Ltd. | G1101 | Tissue fixation |
5.0 Polyglycolic acid absorbable suture | Jinhuan Medical Co., Ltd | KCR531 | Equipment for surgery |
96-well culture plate | Corning Incorporated | CLS3596 | EB content measuring |
Anesthesia machine | Midmark Corporation | VMR | Anesthesia for animal |
Antifade Mounting Medium with DAPI | Beyotime Biotech | P0131 | Mount for tissue sections |
Automation-tissue-dehydrating machine | Leica Biosystems | TP1020 | Dehydrate tissue |
Confocal microscopy | Leica Biosystems | STELLARIS 5 | Image acquisition |
Diclofenac sodium gel | MaYinglong Pharmaceutical | H10950214 | Analgesia for animal |
Eosin staining solution | Servicebio Technology | G1001 | The dye for H&E staining |
Evans Blue | Aladdin | E104208 | EB staining |
Eye gel | Guangzhou Pharmaceutical | H44023098 | Material for surgery |
Fitc-dextran | Sigma-Aldrich | 60842-46-8 | BBB permeability assessing |
Fluorescence microscope | Olympus | BX51 | Image acquisition |
Frozen microtome | Leica Biosystems | CM1900 | Use for frozen sections |
Glucometer | YuWell | 580 | Blood glucose measurement |
Hematoxylin staining Solution | Servicebio | G1004 | The dye for H&E staining |
Iodine | Lircon | 20020059 | Material for surgery |
Isoflurane | Rwd Life Science | R510-22-10 | Anesthesia for animal |
Laser doppler blood flow meter | Moor Instruments | moorVMS | Blood flow monitoring |
MCAO Sutures | Rwd Life Science | 907-00023-01 | Material for surgery |
Meloxicam | Boehringer-Ingelheim | J20160020 | Analgesia for animal |
Microsurgical instrument kit | Rwd Life Science | SP0003-M | Equipment for surgery |
Microtome | Thermo Fisher Scientific | HM325 | Tissue section production |
Microtome blade | Leica Biosystems | 819 | Tissue section production |
Mupirocin ointment | GlaxoSmithKline | H10930064 | Anti-infection for animal |
Neutral balsam | Absin Bioscience | abs9177 | Seal for H&E staining |
Paraffin embedding center | Thermo Fisher Scientific | EC 350 | Produce paraffin blocks |
Pentobarbital sodium | Sigma-Aldrich | P3761 | Euthanasia for animal |
Phosphate buffered saline | Beyotime Biotech | C0221A | Rinse for tissue section |
Scanner | EPSON | V330 | Tissue scanning |
Shaver | Shenzhen Codos Electrical Appliances Co.,Ltd. | CP-9200 | Equipment for surgery |
Spectrophotometer | Thermo Fisher Scientific | 1510-02362 | EB content measuring |
Sucrose solution | Shanghai Macklin Biochemical | 57-50-1 | Dehydration for tissue |
Tissue-Tek O.C.T. Compound | Sakura | 4583 | Tissue embedding medium |
Trichloroacetic acid | Sigma-Aldrich | T6399 | EB content measuring |
Explore More Articles
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved